Last reviewed · How we verify
NCT03151980
The Use of Sun Protection After Hamam (Turkish Bath)
NA trial testing Hamam treated skin and sun exposure in No Medical Condition in 12 participants. Completed in 14 May 2017.
14 May 2017
Quick facts
| Lead sponsor | Herlev and Gentofte Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 12 |
| Start date | 12 May 2017 |
| Primary completion | 14 May 2017 |
| Estimated completion | 14 May 2017 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Hamam treated skin and sun exposure
- Untreated skin and sun exposure
Conditions studied
- No Medical Condition — all drugs for No Medical Condition →
Sponsor
Herlev and Gentofte Hospital
Who can join
18 and older, any sex, with No Medical Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hamam is a common spa treatment. During a Hamam, some of the outermost layer of the skin is removed. The investigators believe that partly removing a protective skin layer might increase the risk of sun burn, especially for skin that has not been exposed to sun for a long time. The aim with this study is to assess if Hamam-treated skin is more susceptible to sun burn compared with untreated skin.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03151980
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Herlev and Gentofte Hospital trials
Trials by the same sponsor.
- NCT07493590 — CAPTURE-HFpEF: National Study of Identification and Phenotyping of Heart Failure With Preserved Ejection Fraction · not yet recruiting
- NCT07321964 — The Effect of a Digital MediYoga Program on Quality of Life, Blood Pressure and Heart Rate Among Patients With Atrial Fi · NA · recruiting
- NCT06706661 — Implementation of Nutritional Efforts on Discharged Older Patients · NA · recruiting
- NCT06618417 — Evaluating the Impact of Home-Based Sleep Apnea Diagnostic on Well-Being, Health Behavior, and AF Load in Patients with · NA · recruiting
- NCT06642272 — A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Hea · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03151980 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Herlev and Gentofte Hospital
- Last refreshed: 9 August 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03151980.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing